Actos (pioglitazone hydrochloride) is an oral anti-diabetic drug manufactured by Takeda and prescribed to decrease blood sugar levels in patients with type 2 diabetes.
A Canada-wide settlement has been reached in five proposed class actions relating to the prescription drugs ACTOS®, APO-Pioglitazone and SANDOZ-Pioglitazone. Hearings were held in the supervising Courts in Québec and Ontario on January 27 and 28, 2021, respectively. The Courts each issued orders approving the national settlement. The settlement is now closed to new claims. The Claims Deadline for the settlement passed on November 29, 2021. All Claims submitted within the Claim Period are currently under review by the Administrator.
For more information, please visit www.piosettlement.ca.
FAQs
What should I do to protect my rights?
To protect your rights, you should:
- Keep a record of medical expenses incurred—appointments not covered by your provincial health care provider, prescriptions, medical devices, etc.
- Keep a record of all medical treatments, including the names and contact information of the health care provider (doctor, surgeon, physiotherapist etc.).
- If possible, keep a journal of symptoms and note down any times when you are unable to attend work or school as a result of your symptoms.
If you have not done so already, contact Siskinds in order that we can contact your health care providers to obtain relevant medical and pharmacy records. As time passes, it can be more difficult to collect this information. All personal information provided to Siskinds regarding any injuries/symptoms you may have suffered will be kept private and confidential.
I still have a question. Who should I contact?
If you have a question, please complete the form on this page or contact us at 1.800.715.4048 or [email protected].